Citations

Showing 10 of 108152 citations.

Augmented Lateral Rectus Recession for Consecutive Exotropia
Nash, David L. , Brodsky, Michael C., Nash, David

Mayo Clinic

Journal of Binocular Vision and Ocular Motility | June 16, 2021 | Volume: 71 | Issue: 3 | Pages: 118-122

10.1080/2576117x.2021.1932226 | PMID 34133249 Get It

Deciphering the interactions of SARS-CoV-2 proteins with human ion channels using machine learning-based method
Munjal, Nupur S., Sapra, Dikscha , Goyal, Abhishek , Parthasarathi, Kaushik , Banerjee, Manidipa , Parthasarathi, K.T. Shreya, Pandey, Akhilesh , Sharma, Jyoti

Mayo Clinic

No container title available | June 16, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-622770/v1 Get It

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the worldwide COVID-19 pandemic which began in 2019. It has a high transmission rate and pathogenicity leading to health emergencies and economic crisis. Recent studies pertaining to the understanding of the molecular pathogenesis of SARS-CoV-2 infection exhibited the indispensable role of ion channels in viral infection inside the host. Moreover, machine learning-based algorithms are providing higher accuracy for host-SARS-CoV-2 protein-protein interactions (PPIs). In this study, predictions of PPIs of SARS-CoV-2 proteins with human ion channels (HICs) were performed using PPI-MetaGO algorithm. The PPIs were predicted with 82.71% accuracy, 84.09% precision, 84.09% sensitivity, 0.89 AUC-ROC, 65.17% MCC score and 84.09% F1 score. Thereafter, PPI networks of SARS-CoV-2 proteins with HICs were generated. Furthermore, biological pathway analysis of HICs interacting with SARS-CoV-2 proteins showed the involvement of six pathways, namely inflammatory mediator regulation of TRP channels, insulin secretion, renin secretion, gap junction, taste transduction and apelin signaling pathway. The inositol 1,4,5-trisphosphate receptor 1 (ITPR1) and transient receptor potential cation channel subfamily A member 1 (TRPA1) were identified as potential target proteins. Various FDA approved drugs interacting with ITPR1 and TRPA1 are also available. It is anticipated that targeting ITPR1 and TRPA1 may provide a better therapeutic management of infection caused by SARS-CoV-2. The study also reinforces the drug repurposing approach for the development of host directed antiviral drugs.
The Evolving Challenge of Infections in Cirrhosis
Bajaj, Jasmohan S. , Kamath, Patrick S. , Reddy, K. Rajender

Mayo Clinic

New England Journal of Medicine | June 16, 2021 | Volume: 384 | Issue: 24 | Pages: 2317-2330

10.1056/nejmra2021808 | PMID 34133861 Get It

Better Anticoagulated Than Not! Hypercoagulability in COVID-19
Karam, Dhauna , Karam, Dhauna P

Mayo Clinic

JCO Oncology Practice | June 16, 2021 | Volume: 17 | Issue: 9 | Pages: 522-523

10.1200/op.21.00359 | PMID 34133217 Get It

Evaluation of Self-Collected Midturbinate Nasal Swabs and Saliva for Detection of SARS-CoV-2 RNA
Boerger, Aimee C. , Buckwalter, Seanne P., Fernholz, Emily C. , Jannetto, Paul J. , Binnicker, Matthew J. , Reed, Katelyn A. , Walchak, Robert C., Woodliff, Ethan D., Johnson, Michael , Pritt, Bobbi S. , Buckwalter, Seanne, Reed, Katelyn, Walchak, Robert, Woodliff, Ethan, Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | June 16, 2021 | Volume: 59 | Issue: 9 | Pages: No page available

10.1128/jcm.00848-21 | PMID 34132579 Get It

Rapid and accurate diagnostic testing is essential to bring the ongoing COVID-19 pandemic to an end. As the demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing continues to increase amid supply shortages, many laboratories have investigated the use of sources other than nasopharyngeal (NP) swabs.
Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates
Shamim, Huma, Davis, Mark D.P., Wetter, David A. , Newman, Catherine C., Comfere, Nneka I. , Sokumbi, Olayemi

Mayo Clinic

The American Journal of Dermatopathology | June 16, 2021 | Volume: 43 | Issue: 10 | Pages: 714-720

10.1097/dad.0000000000001875 | PMID 34132660 Get It

Background: Observations highlighting the “unmasking” of cutaneous T-cell lymphoma after treatment with dupilumab for atopic dermatitis (AD) have been recently reported. However, there remains a paucity of literature describing the evolution of clinical and histopathological features that characterizes this phenomenon. Objective: To define the clinical and histopathologic evolution of atypical lymphoid infiltrates after the administration of dupilumab for AD. Methods: A cross-sectional study of clinical and histopathologic features in 7 consecutive patients with a diagnosis of “atypical lymphoid infiltrate” or mycosis fungoides (MF) on dupilumab for AD was performed. Results: Seven patients with atypical lymphoid infiltrates or MF in evolution after dupilumab therapy (age range 27–74 years) were reviewed. Average duration of AD before MF diagnosis was 5.7 years, and the average duration on dupilumab treatment was 9.8 months. Notable histopathologic features across predupilumab and postdupilumab biopsies included progressive increase in the densities of the atypical lymphoid infiltrates (7/7), presence of atypical epidermotropic lymphocytes (6/7), and papillary dermal fibrosis (6/7). Limitations: Small retrospective cohort study. Conclusion: These cases highlight the transformation of lymphoid infiltrates after dupilumab treatment for AD and emphasize the importance of clinical and histopathologic evaluation before and during treatment with dupilumab for treatment-refractory presumed AD.
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy
Puranik, Amrutesh S. , Jiang, Kai , Chen, Xiaojun , Zhu, Xiangyang , Taylor, Ian , Khodadadi‐Jamayran, Alireza , Hickson, LaTonya J. , Childs, Bennett G. , Textor, Stephen C., Niewold, Timothy B. , Kirkland, James L. , Lerman, Lilach O. , Kim, Seo Rin , Puranik, Amrutesh S , Khodadadi-Jamayran, Alireza , Tchkonia, Tamara, Lerman, Lilach O , Hickson, LaTonya J , Lerman, Amir , Tchkonia, Tamar

Mayo Clinic

Journal of the American Society of Nephrology | June 16, 2021 | Volume: 32 | Issue: 8 | Pages: 1987-2004

10.1681/asn.2020091373 | PMID 34135081 Get It

Significance Statement Renal artery stenosis (RAS) engenders stenotic-kidney ischemia, dysfunction, and injury, but whether these are mediated by cellular senescence has not been elucidated. INK-ATTAC transgenic mice, high-resolution imaging, and unbiased single-cell RNA sequencing of murine kidneys demonstrated cellular senescence as an important mechanism of progressive injury to epithelial/stromal cells within poststenotic kidneys. Both p16-specific and broad quercetin/dasatinib interventions to blunt senescence improved renal function and structure, underscoring the central role of senescence in the pathogenesis. Furthermore, this mechanism was conserved in human subjects with RAS. These observations reveal new mechanisms that contribute to the pathogenesis of chronic ischemic renal injury, and support the development of senolytic therapy to reduce senescent cell burden and delay renal injury. Background Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery stenosis (RAS) induces stenotic-kidney dysfunction and injury, but whether these arise from cellular senescenceand their temporal pattern remain unknown. Methods Chronic renal ischemia was induced in transgenic INK-ATTAC and wild type C57BL/6 mice by unilateral RAS, and kidney function ( in vivo micro-MRI) and tissue damage were assessed. Mouse healthy and stenotic kidneys were analyzed using unbiased single-cell RNA-sequencing. To demonstrate translational relevance, cellular senescence was studied in human stenotic kidneys. Results Using intraperitoneal AP20187 injections starting 1, 2, or 4 weeks after RAS, selective clearance of cells highly expressing p16 Ink4a attenuated cellular senescence and improved stenotic-kidney function; however, starting treatment immediately after RAS induction was unsuccessful. Broader clearance of senescent cells, using the oral senolytic combination dasatinib and quercetin, in C57BL/6 RAS mice was more effective in clearing cells positive for p21 ( Cdkn1a ) and alleviating renal dysfunction and damage. Unbiased, single-cell RNA sequencing in freshly dissociated cells from healthy and stenotic mouse kidneys identified stenotic-kidney epithelial cells undergoing both mesenchymal transition and senescence. As in mice, injured human stenotic kidneys exhibited cellular senescence, suggesting this process is conserved. Conclusions Maladaptive tubular cell senescence, involving upregulated p16 ( Cdkn2a ), p19 ( Cdkn2d ), and p21 ( Cdkn1a ) expression, is associated with renal dysfunction and injury in chronic ischemia. These findings support development of senolytic strategies to delay chronic ischemic renal injury.
A Still-Ignored Cardiovascular Risk Factor—A History of Preeclampsia—Reply
Dugani, Sagar B. , Moorthy, M. Vinayaga , Mora, Samia , Dugani, Sagar B , Mora, Samia

Mayo Clinic

JAMA Cardiology | June 16, 2021 | Volume: 6 | Issue: 9 | Pages: 1098

10.1001/jamacardio.2021.1961 | PMID 34132737 Get It

Concomitant Pheochromocytoma and Primary Aldosteronism: A Case Series and Literature Review
Mao, Jimmy , Baker, Jessica , Rainey, William E. , Mao, Jimmy J , Bancos, Irina , Young, William F. , Bancos, Irina

Mayo Clinic

Journal of the Endocrine Society | June 16, 2021 | Volume: 5 | Issue: 8 | Pages: No page available

10.1210/jendso/bvab107 | PMID 34258494 Get It

Abstract Context The detection and management of concomitant pheochromocytoma (PHEO) and primary aldosteronism (PA) is not well understood. Objective To investigate varying presentations and outcomes of cases with coexisting PHEO and PA to provide an approach to its diagnosis and management. Methods We conducted a retrospective case series of adult patients with concomitant PHEO and PA at Mayo Clinic from 2000-2020 and an additional review of cases before 2000 and from the medical literature. Clinical, biochemical, radiologic, and histologic parameters were measured. Results Fifteen patients (53% men, median age 53 years) were diagnosed with concomitant PHEO and PA. The majority presented with hypertension (13, 87%) and hypokalemia (13, 87%), and 6 (40%) presented with symptoms suggestive of catecholamine excess. All patients who underwent preoperative workup for catecholamine excess (14, 93%) were found to have biochemical levels above the upper limits of normal. Adrenal vein sampling (AVS) was performed in 9 patients (60%), where 5 (56%) were diagnosed with bilateral PA, and 4 (44%) with unilateral PA. Patients underwent either unilateral (12, 80%) or bilateral (3, 20%) adrenalectomy. Biochemical improvement or resolution of catecholamine excess was confirmed in all cases with documented measurements. Recurrence of PHEO was not observed. Six patients (40%) displayed persistent PA postoperatively. Conclusion Concomitant PHEO and PA is a rare but likely underreported condition. Hypertension with or without hypokalemia should prompt evaluation for PA, while any indeterminate adrenal mass should be assessed for PHEO. Coexisting disease warrants consideration of AVS to determine the laterality of PA to ensure appropriate management.